Trial Profile
Rivaroxaban in patients with symptomatic chronic heart failure
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Thromboembolism
- Focus Biomarker; Pharmacodynamics
- 05 Nov 2010 New trial record.